Pantoprazole and cholestasis Patient Reports February 13, 2012

Pantoprazole Side Effects Report #4948176-1
Pantoprazole side effect was reported by a Consumer or non-health professional from SWITZERLAND on Feb 27, 2006. Female patient, 83 years of age, was diagnosed with gastric ulcer, pain , epilepsy , secondary hypertension and was treated with Pantoprazole. After drug was administered, patient experienced the following side effects: cholestasis, condition aggravated, hepatic failure, jaundice . Pantoprazole dosage: 40 MG 1X PER 1 DAY. During the same period patient was treated with ARTHROTEC, PHENOBARBITAL, PLENDIL. Patient was hospitalized. Patient died.

Pantoprazole Side Effects Report #5055181-6
Pantoprazole side effect was reported by a Health Professional from GERMANY on July 04, 2006. Female patient, 77 years of age, was diagnosed with gastric disorder, gastrooesophageal reflux disease and was treated with Pantoprazole. After drug was administered, patient experienced the following side effects: biliary dilatation, cholestasis, coagulopathy, coma hepatic, cryptogenic cirrhosis, gallbladder polyp, hepatic atrophy, hepatic cirrhosis. Pantoprazole dosage: 40 MG 1X PER 1 DAY, ORAL. Patient was hospitalized. Patient died.

Pantoprazole Side Effects Report #5165430-1
Pantoprazole side effect was reported by a Consumer or non-health professional from NETHERLANDS on Nov 15, 2006. Female patient, 84 years of age, was diagnosed with dyspepsia, venous insufficiency and was treated with Pantoprazole. After drug was administered, patient experienced the following side effects: biopsy liver abnormal, cholestasis, hepatic function abnormal, hepatic steatosis, hepatotoxicity, hyperbilirubinaemia, inflammation, malabsorption. Pantoprazole dosage: 40 MG 1X PER 1 DAY ORAL. During the same period patient was treated with VENORUTON, ATENOLOL, THYRAX, ACETYLSALICYLATE CALCIUM, CARBASALATE CALCIUM. Patient was hospitalized. Patient recovered.

Pantoprazole Side Effects Report #5146070-7
Pantoprazole side effect was reported by a Consumer or non-health professional from FRANCE on Oct 20, 2006. Female patient, 42 years of age, was diagnosed with dyspepsia and was treated with Pantoprazole. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, cholelithiasis, cholestasis, cytolytic hepatitis. Pantoprazole dosage: unknown. During the same period patient was treated with ANAFRANIL, GAVISCON, IMOVANE, SPASFON. Patient was hospitalized. Patient recovered.


Pantoprazole Side Effects Report #5710917-3
Pantoprazole side effect was reported by a Physician from FRANCE on Apr 11, 2008. Female patient, 55 years of age, weighting 143.3 lb, was diagnosed with abdominal pain upper, chronic myeloid leukaemia and was treated with Pantoprazole. After drug was administered, patient experienced the following side effects: abdominal pain upper, cholestasis, cytolytic hepatitis, gamma-glutamyltransferase increased, hepatic fibrosis, jaundice . Pantoprazole dosage: unknown. During the same period patient was treated with GLEEVEC. Patient recovered.

Pantoprazole Side Effects Report #5106888-3
Pantoprazole side effect was reported by a Consumer or non-health professional from FRANCE on Aug 31, 2006. Male patient, 44 years of age, was diagnosed with juvenile arthritis, depression  and was treated with Pantoprazole. After drug was administered, patient experienced the following side effects: atrophy, autoimmune hepatitis, biliary tract disorder, cholangitis sclerosing, cholestasis, condition aggravated, cytolytic hepatitis, hepatic steatosis, hepatocellular damage. Pantoprazole dosage: unknown. During the same period patient was treated with PREDNISONE, ELAVIL, LANSOPRAZOLE, PROZAC, TERCAN. Patient was hospitalized. Patient recovered.

Pantoprazole Side Effects Report #5162142-5
Pantoprazole side effect was reported by a Health Professional from FRANCE on Nov 08, 2006. Male patient, 44 years of age, was diagnosed with juvenile arthritis, depression  and was treated with Pantoprazole. After drug was administered, patient experienced the following side effects: autoimmune hepatitis, c-reactive protein increased, cholestasis, condition aggravated, granulomatous liver disease, hepatic atrophy, hepatic steatosis, hepatocellular damage, inflammation. Pantoprazole dosage: unknown. During the same period patient was treated with PREDNISONE, ELAVIL, LANSOPRAZOLE, PROZAC, TERCIAN. Patient was hospitalized. Patient recovered.